Rifampin Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Rifampin Capsule (capsule) from Lupin Pharmaceuticals, Inc. with status Current. The shortage was first posted on 12/22/2021. Reported reason: Shortage of an active ingredient
Shortage Details
- Status
- Current
- Company
- Lupin Pharmaceuticals, Inc.
- Package NDC
- 68180-659-06
- Dosage Form
- Capsule
- Presentation
- Rifampin, Capsule, 300 mg (NDC 68180-659-06)
- Initial Posting
- 12/22/2021
- Revised Date
Reason
Shortage of an active ingredient